Pfizer says early COVID-19 vaccine data suggests its shots may be 90 per cent effective. But that figure could change

The interim analysis, from an independent data monitoring board, looked at 94 infections recorded so far in a study that has enrolled nearly 44,000 people in the US and five other countries. It does not mean a vaccine is imminent.